4.6 Article

Z-disc-associated, Alternatively Spliced, PDZ Motif-containing Protein ( ZASP) Mutations in the Actin-binding Domain Cause Disruption of Skeletal Muscle Actin Filaments in Myofibrillar Myopathy

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 289, Issue 19, Pages 13615-13626

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M114.550418

Keywords

Actin; Muscular Dystrophy; Protein Complex; Protein-Protein Interaction; Skeletal Muscle; Actinin; Myofibrillar Myopathy; Myotilin; Z-disc; ZASP

Funding

  1. NINDS, National Institute of Health

Ask authors/readers for more resources

Background: The binding partners of the ZASP internal region that is mutated in zaspopathy are not yet known. Results: The internal region of ZASP binds to skeletal muscle -actin, and zaspopathy mutations cause actin disruption. Conclusion: ZASP mutations in the actin-binding domain are deleterious to the muscle Z-disc structure. Significance: ZASP-actin interaction expands the role of ZASP and defines the mechanism of zaspopathy. The core of skeletal muscle Z-discs consists of actin filaments from adjacent sarcomeres that are cross-linked by -actinin homodimers. Z-disc-associated, alternatively spliced, PDZ motif-containing protein (ZASP)/Cypher interacts with -actinin, myotilin, and other Z-disc proteins via the PDZ domain. However, these interactions are not sufficient to maintain the Z-disc structure. We show that ZASP directly interacts with skeletal actin filaments. The actin-binding domain is between the modular PDZ and LIM domains. This ZASP region is alternatively spliced so that each isoform has unique actin-binding domains. All ZASP isoforms contain the exon 6-encoded ZASP-like motif that is mutated in zaspopathy, a myofibrillar myopathy (MFM), whereas the exon 8-11 junction-encoded peptide is exclusive to the postnatal long ZASP isoform (ZASP-Lex10). MFM is characterized by disruption of skeletal muscle Z-discs and accumulation of myofibrillar degradation products. Wild-type and mutant ZASP interact with -actin, -actinin, and myotilin. Expression of mutant, but not wild-type, ZASP leads to Z-disc disruption and F-actin accumulation in mouse skeletal muscle, as in MFM. Mutations in the actin-binding domain of ZASP-Lex10, but not other isoforms, cause disruption of the actin cytoskeleton in muscle cells. These isoform-specific mutation effects highlight the essential role of the ZASP-Lex10 isoform in F-actin organization. Our results show that MFM-associated ZASP mutations in the actin-binding domain have deleterious effects on the core structure of the Z-discs in skeletal muscle.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Clinical Neurology

Long Exercise Test in Periodic Paralysis: A Bayesian Analysis

Daniel B. Simmons, Julie Lanning, James C. Cleland, Araya Puwanant, Paul T. Twydell, Robert C. Griggs, Rabi Tawil, Eric L. Logigian

MUSCLE & NERVE (2019)

Review Pediatrics

Progress in treatment and newborn screening for Duchenne muscular dystrophy and spinal muscular atrophy

Qing Ke, Zheng-Yan Zhao, Jerry R. Mendell, Mei Baker, Veronica Wiley, Jennifer M. Kwon, Lindsay N. Alfano, Anne M. Connolly, Catherine Jay, Hanna Polari, Emma Ciafaloni, Ming Qi, Robert C. Griggs, Michele A. Gatheridge

WORLD JOURNAL OF PEDIATRICS (2019)

Article Oncology

The TYRP1-mediated protection of human tyrosinase activity does not involve stable interactions of tyrosinase domains

Monika B. Dolinska, Paul T. Wingfield, Kenneth L. Young, Yuri V. Sergeev

PIGMENT CELL & MELANOMA RESEARCH (2019)

Review Clinical Neurology

Maximizing the Benefit of Life-Saving Treatments for Pompe Disease, Spinal Muscular Atrophy, and Duchenne Muscular Dystrophy Through Newborn Screening: Essential Steps

Mei Baker, Robert Griggs, Barry Byrne, Anne M. Connolly, Richard Finkel, Lucja Grajkowska, Amanda Haidet-Phillips, Laura Hagerty, Robert Ostrander, Lianna Orlando, Kathryn Swoboda, Michael Watson, R. Rodney Howell

JAMA NEUROLOGY (2019)

Letter Clinical Neurology

Author response: Michael H. Brooke, MB, BCh (1934-2018)

Robert C. Griggs, Jerry R. Mendell

NEUROLOGY (2019)

Article Clinical Neurology

Efficacy and Safety of Dichlorphenamide for Primary Periodic Paralysis in Adolescents Compared With Adults

Emma Ciafaloni, Fredric Cohen, Robert Griggs

PEDIATRIC NEUROLOGY (2019)

Article Biochemistry & Molecular Biology

Capsids of hepatitis B virus e antigen with authentic C termini are stabilized by electrostatic interactions

Norman R. Watts, Ira W. Palmer, Elif Eren, Alasdair C. Steven, Paul T. Wingfield

FEBS LETTERS (2020)

Article Biochemistry & Molecular Biology

Protein Stability and Functional Characterization of Intra-Melanosomal Domain of Human Recombinant Tyrosinase-Related Protein 1

Monika B. Dolinska, Kenneth L. Young, Claudia Kassouf, Emilios K. Dimitriadis, Paul T. Wingfield, Yuri V. Sergeev

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)

Article Clinical Neurology

Intracellular calcium leak as a therapeutic target for RYR1-related myopathies

Alexander Kushnir, Joshua J. Todd, Jessica W. Witherspoon, Qi Yuan, Steven Reiken, Harvey Lin, Ross H. Munce, Benjamin Wajsberg, Zephan Melville, Oliver B. Clarke, Kaylee Wedderburn-Pugh, Anetta Wronska, Muslima S. Razaqyar, Irene C. Chrismer, Monique O. Shelton, Ami Mankodis, Christopher Grunseich, Mark A. Tarnopolsky, Kurenai Tanji, Michio Hirano, Sheila Riazi, Natalia Kraeva, Nicol C. Voermans, Angela Gruber, Carolyn Allen, Katherine G. Meilleur, Andrew R. Marks

ACTA NEUROPATHOLOGICA (2020)

Article Clinical Neurology

Cardiac MRI identifies valvular and myocardial disease in a subset of ANO5-related muscular dystrophy patients

Ranjini Srinivasan, Pomi Yun, Sarah Neuhaus, Payam Mohassel, Jahannaz Dastgir, Sandra Donkervoort, Alice Schindler, Ami Mankodi, A. Reghan Foley, Andrew E. Arai, Carsten G. Bonnemann

NEUROMUSCULAR DISORDERS (2020)

Article Clinical Neurology

Skeletal Muscle Magnetic Resonance Biomarkers in GNE Myopathy

Chia-Ying Liu, Jianhua Yao, William C. Kovacs, Joseph A. Shrader, Galen Joe, Ronald Ouwerkerk, Ami K. Mankodi, William A. Gahl, Ronald M. Summers, Nuria Carrillo

Summary: This study characterized muscle involvement and disease severity in patients with GNE myopathy using skeletal muscle MRI and proton magnetic resonance spectroscopy. The findings showed that muscle volume correlated with strength, function, and patient-reported outcomes, indicating the potential of MRI biomarkers to monitor disease progression noninvasively.

NEUROLOGY (2021)

Editorial Material Clinical Neurology

246th ENMC International Workshop: Protein aggregate myopathies 24-26 May 2019, Hoofddorp, The Netherlands

Montse Olive, Lilli Winter, Dieter O. Fuerst, Rolf Schroeder

NEUROMUSCULAR DISORDERS (2021)

Article Biology

Myopathy associated LDB3 mutation causes Z-disc disassembly and protein aggregation through PKCα and TSC2-mTOR downregulation

Pankaj Pathak, Yotam Blech-Hermoni, Kalpana Subedi, Jessica Mpamugo, Charissa Obeng-Nyarko, Rachel Ohman, Ilda Molloy, Malcolm Kates, Jessica Hale, Stacey Stauffer, Shyam K. Sharan, Ami Mankodi

Summary: This research demonstrates that the LDB3 protein regulates mechanical stress signaling through interactions with filamin C, HSPA8, and PKC alpha. Mutations in LDB3 lead to early aggregation of filamin C and its chaperones at the muscle Z-disc, ultimately causing protein aggregation myopathy.

COMMUNICATIONS BIOLOGY (2021)

Review Clinical Neurology

N-of-1 Trials in Neurology A Systematic Review

Bas C. Stunnenberg, Joost Berends, Robert C. Griggs, Jeffrey Statland, Gea Drost, Jane Nikles, Hans Groenewoud, Baziel G. M. van Engelen, Wilt Jan van der Gert, Joost Raaphorst

Summary: This study conducted a systematic review of published N-of-1 trials in neurologic disorders, focusing on methodological quality and reporting. Most trials were in neuromuscular and neurodegenerative/movement disorders, with applications in stable chronic conditions and progressive or acute disorders. N-of-1 trials show potential for bridging the gap between research and clinical care by providing a personalized evidence base for suitable treatments.

NEUROLOGY (2022)

Article Clinical Neurology

Improved Criteria for the Classification of Titin Variants in Inherited Skeletal Myopathies

Marco Savarese, Mridul Johari, Katherine Johnson, Meharji Arumilli, Annalaura Torella, Ana Topf, Anna Rubegni, Marius Kuhn, Teresa Giugliano, Dieter Glaeser, Fabiana Fattori, Rachel Thompson, Sini Penttila, Sara Lehtinen, Sara Gibertini, Alessandra Ruggieri, Marina Mora, Ales Maver, Borut Peterlin, Ami Mankodi, Hanns Lochmueller, Filippo Maria Santorelli, Benedikt Schoser, Lenka Fajkusova, Volker Straub, Vincenzo Nigro, Peter Hackman, Bjarne Udd

JOURNAL OF NEUROMUSCULAR DISEASES (2020)

No Data Available